Mohammad-Mahdi Rashidi
University of Oxford, World Health Organization, Shahid Beheshti University of Medical Sciences, Digikala
Research areas: Medicine · Public Health, Environmental and Occupational Health · Global Health and Epidemiology · Global Cancer Incidence and Screening · Diabetes, Cardiovascular Risks, and Lipoproteins
About
Dr Mohammad-Mahdi Rashidi is a medical doctor and epidemiologist whose work focuses on noncommunicable diseases, population health, health metrics, health inequalities, evidence synthesis and guideline development. He is an Honorary Researcher with the Deep Medicine team at the Nuffield Department of Women’s & Reproductive Health, University of Oxford, a Consultant in the Noncommunicable Diseases and Mental Health Department at the World Health Organization Headquarters, and a Senior Researcher at the Non-Communicable Diseases Research Centre, Tehran University of Medical Sciences.
He completed his Doctor of Medicine degree at Shahid Beheshti University of Medical Sciences, Tehran, supported by a full scholarship. He began research during medical school at the Social Determinants of Health Research Centre, where he developed an early interest in epidemiology, public health and inequalities in health and healthcare.
Dr Rashidi joined the Non-Communicable Diseases Research Centre in 2020 and served as Head of its Epidemiology Unit from 2021 to 2023. He coordinated population-health and noncommunicable disease research, contributed to study design and analysis, supported junior researchers, and helped translate findings into policy-relevant outputs. He continues to collaborate with the centre as a Senior Researcher.
At WHO, he contributes to the development of global guidance on chronic respiratory diseases, particularly asthma and chronic obstructive pulmonary disease. His work includes developing PICO questions, contributing to GRADE Evidence-to-Decision frameworks, reviewing systematic review and methodological proposals, coordinating Guideline Development Group processes, and drafting technical and policy-oriented outputs.
He is a Senior Collaborator with the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation and a collaborator with the NCD Risk Factor Collaboration at Imperial College London. Through these roles, he has contributed to large-scale analyses of disease burden, risk factors, healthcare quality, population trends and health inequalities.
His perspective is also informed by approximately two years of independent clinical practice as a primary care physician in underserved and socioeconomically disadvantaged urban communities, where he gained direct insight into patients’ priorities and the practical barriers to delivering continuous, guideline-concordant care.
Dr Rashidi has authored or co-authored more than 130 peer-reviewed publications, including original research, evidence syntheses and large international collaborative studies. His work includes first-author research on the epidemiology and determinants of noncommunicable diseases, analyses of disease burden and quality of care, and contributions to studies published in journals including The Lancet, The Lancet Neurology, The Lancet Global Health, The Lancet Public Health, Nature Medicine, EClinicalMedicine, Scientific Reports and Clinical Kidney Journal.
His main research interests include:
1. Health inequalities and quality of care: examining socioeconomic, demographic and geographical variation in access to effective healthcare, treatment coverage and outcomes.
2. Noncommunicable disease epidemiology: using national surveys, routinely collected data and international datasets to study cardiovascular, respiratory and metabolic conditions.
3. Health metrics and health-system performance: assessing disease burden, risk factors, quality-of-care indicators and health-system performance.
4. Routine health data and electronic health records: evaluating guideline-concordant care, identifying unwarranted variation and supporting healthcare improvement.
5. Evidence synthesis and guideline development: contributing to systematic reviews, critical appraisal, GRADE assessments and Evidence-to-Decision frameworks.
His current work at Oxford focuses increasingly on cardiovascular epidemiology, primary care quality and inequalities in healthcare delivery. He is developing research using linked electronic health records to examine whether people with major cardiovascular conditions receive recommended care equitably across socioeconomic and demographic groups.
His longer-term aim is to establish an independent programme of applied epidemiological and health-services research that combines rigorous analysis of routine health data with patient, clinical and policy perspectives. His work seeks to identify avoidable gaps in care, develop practical measures of healthcare inequality and support more equitable, transparent and evidence-based health systems.
Dr Rashidi’s academic distinctions include recognition as the Top Researcher at the National and International Festival on Research Thesis, the Khayyam Award, in 2020, a National Bronze Medal in the Iranian Chemistry Olympiad, and a top 0.04% ranking in Iran’s national university entrance examination.
Employment
-
University of Oxford Visiting researcher2025 - Present
-
World Health Organization Consultant2024 - Present
-
Digikala Occupational Health Physician / General Practitioner2023 - 2025
-
Independent medical practice General Practitioner2023 - 2025
-
Tehran University of Medical Sciences Non-Communicable Diseases Research Center Research Fellow2020 - 2024
Education
-
Shahid Beheshti University of Medical Sciences Doctor of Medicine2013 - 2020
Projects & Funding
-
Evaluation of the Influencing Factors on the Quality of Glycemic Control Using Data of Iran Health Insurance Organization and National Survey of Stepwise Approach to Non-Communicable Risk Factors Surveillance (STEPS) 2016 Tehran University of Medical Sciences2021 - 2023
-
STEPwise approach to non-communicable diseases (NCD) risk factor surveillance (STEPs) 2021 National Institute of Health Researches of Iran2020 - 2022
Publications (178)
- WHO guidance for asthma and chronic obstructive pulmonary disease: why it matters Save
- Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021 Save
- An exciting new chapter for chronic respiratory diseases Save
- Burden of osteoarthritis in North Africa and Middle East from 1990 to 2021: findings from the Global Burden of Disease 2021 study Save
- 1 Healthcare-Delivered Lifestyle Recommendations 2 and Their Association with Health Behaviors in Iran Save
- American Heart Association’s Life’s Simple 7 for cardiovascular health assessment among Iranian adults: a national cross-sectional study from STEPwise approach to non-communicable diseases risk factor surveillance (STEPS) survey 2021 Save
- Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9) Save
- Author Correction: Obesity rise plateaus in developed nations and accelerates in developing nations Save
- Correction: Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran (Scientific Reports, (2026), 16, 1, (10825), 10.1038/s41598-026-45344-0) Save
- Correction: Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim-Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019 (BMC Public Health, (2024), 24, 1, (3… Save
- Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran Save
- Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study Save
- Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study Save
- Menopausal timing and its determinants among Iranian women: findings from the 2021 national STEPS survey Save
- Obesity rise plateaus in developed nations and accelerates in developing nations Save
- Prevalence and risk factors of chronic kidney disease among Iranian adults with and without diabetes: a cross-sectional study using STEPS 2021 national survey Save
- Salt Intake Among the Iranian Population and Public Attitudes Toward Salt Consumption: National and Subnational Report From STEPS 2021 Save
- Prevalence and associated factors of asthma and COPD among adults in Iran based on the 2021 STEPS survey Save
- Key advocacy messages for chronic respiratory diseases Save
- Over-time changes in the prevalence of metabolic syndrome and its components among elderly population in Iran from 2016 to 2021; A nation-wide study Save